HIGHLIGHTS
- who: Fabrizio Dal Moro from the Padova, Padova, Italy have published the research: The Role of Lymph Node Dissection in the Treatment of Bladder Cancer, in the Journal: (JOURNAL)
- what: Another randomized clinical trial of the National Cancer Institute (SWOG 1011), active in USA and Canada, is still in progress, with the primary aim of examining disease free survival of extended (including common iliac and presacral PLND) vs. standard PLND .
SUMMARY
LND is an essential step in the treatment of MIBC because it is known that approximately 25-30% of patients . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.